Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized Treatment Strategies for Stage II/III Nasopharyngeal Carcinoma
NCT03908372Phase 3Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jun 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in nasopharyngeal squamous cell carcinoma, sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
docetaxel
03
Conditions
nasopharyngeal squamous cell carcinoma
Beyond the preview
Go deeper on NCT03908372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03908372.